Congratulations to the inaugural winner of the 2010 Merck Sharp and Dohme
Translational Research Excellence Commercialisation Award:

Vaxxas (Nanopatch) - Prof. Mark Kendall and Dr. Don Kakuda

Merck Sharp and Dohme generously offered a prize of up to AU$10,000 towards travel and associated costs to join the Queensland Delegation to BIO2011 and the opportunity to present the technology to senior Merck Sharpe and Dohme Executives. 
 
The Award Winner was announced on Friday 15 October 2010 at the Queensland Life Sciences Globally Engaging Networking Event (GENE).
 
If you would like more information you are welcome to contact Clare Schodel or Dominic Ward, via the details below:   
 
Clare Schodel 
Marketing Manager
Queensland Clinical Trials Network Inc.
P: +61 (0)7 3331 3930   |   F: +61 (0)7 3870 9101   |   E: marketing@qctn.com.au

Dominic Ward
Principal Project Officer,
Biotechnology Commercialisation Pipeline
Business Innovation
Office of Advanced Manufacturing
Department of Employment, Economic Development and Innovation
P: 07 3405 5487   |   F: +61 (0)7 3225 8754   |   M: 0411 653 460   |   E: dominic.ward@qld.gov.au